When postural hypotension signals disease.
D000317:Adrenergic alpha-Antagonists / Q000009:adverse effects; D000368:Aged; D000928:Antidepressive Agents / Q000009:adverse effects; D001810:Blood Volume; D001927:Brain Diseases / Q000150:complications*; D002302:Cardiac Output; D002318:Cardiovascular Diseases / Q000150:complications*; D004295:Dihydroxyphenylalanine / Q000009:adverse effects; D004232:Diuretics / Q000009:adverse effects; D005438:Fludrocortisone / Q000627:therapeutic use; D006801:Humans; D006993:Hypnotics and Sedatives / Q000009:adverse effects; D007024:Hypotension, Orthostatic / Q000139:chemically induced / Q000175:diagnosis / Q000209:etiology* / Q000628:therapy; D010523:Peripheral Nervous System Diseases / Q000150:complications*; D012964:Sodium / Q000378:metabolism; D012965:Sodium Chloride / Q000627:therapeutic use; D013118:Spinal Cord Diseases / Q000150:complications*; D013564:Sympathetic Nervous System / Q000187:drug effects; D014149:Tranquilizing Agents / Q000009:adverse effects
D000317:Adrenergic alpha-Antagonists; D000928:Antidepressive Agents; D004232:Diuretics; D006993:Hypnotics and Sedatives; D014149:Tranquilizing Agents; D012965:Sodium Chloride; D004295:Dihydroxyphenylalanine; D012964:Sodium; D005438:Fludrocortisone